Quarterly ResultAug 5, 2026, 04:32 PM
Encompass Health Q2 Revenue $1.6B, Raises FY Guidance
AI Summary
Encompass Health reported strong second-quarter 2026 financial results, with net operating revenue increasing 9.6% to $1.597 billion and Adjusted EBITDA growing 9.2% to $348.0 million. Adjusted earnings per share rose 10.7% to $1.55. Following this performance, the company increased its full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted EPS. Additionally, the board approved an increase in the common stock repurchase authorization to $1 billion.
Key Highlights
- Q2 2026 net operating revenue increased 9.6% to $1,597.4 million.
- Q2 2026 Adjusted EBITDA grew 9.2% to $348.0 million.
- Q2 2026 Adjusted earnings per share rose 10.7% to $1.55.
- Full-year 2026 revenue guidance raised to $6,410-$6,490 million.
- Full-year 2026 Adjusted EBITDA guidance raised to $1,365-$1,395 million.
- Full-year 2026 Adjusted EPS guidance raised to $6.02-$6.25.
- Common stock repurchase authorization increased to $1 billion.
- Repurchased $145.8 million of common stock year-to-date.
Price Impact
More from EHC